Somayeh Mahdinloo

Somayeh Mahdinloo

Auto-generated profile, based on publicly available information

Somayeh Mahdinloo

Guangzhou Institute of Cancer Research, the Afiliated Cancer Hospital & School of Biomedical Engineering Guangzhou Medical University Guangzhou China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
MSMaryam Saadat
Maryam Saadat
FMFarid Mostafaei
Farid Mostafaei
SMSomaye Mahdinloo
Somaye Mahdinloo
MAMahdieh Abdi
Mahdieh Abdi
FZFahimeh Zahednezhad
Fahimeh Zahednezhad
HVHadi Valizadeh
Hadi Valizadeh

1 October 2023 in Nanomedicine
Verified
Journal Article
Closed access
FMFarid Mostafaei
Farid Mostafaei
SMSomayeh Mahdinloo
Somayeh Mahdinloo
HVHadi Valizadeh
Hadi Valizadeh
SHSalar Hemmati
Salar Hemmati
MAMahdieh Abdi
Mahdieh Abdi
PMParvin Milani-Zakeri
Parvin Milani-Zakeri
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, typically diagnosed in advanced stages. Chemotherapy is necessary for treating advanced liver cancer; however, severa... Plain language summary Liver cancer is the third leading cause of cancer deaths in the world that is usually diagnosed in the last stages. Chemotherapy is commonly used to treat advanced liver canc... Graphical abstract

10 December 2022 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
HVHadi Valizadeh
Hadi Valizadeh
SMSomayeh Mahdinloo
Somayeh Mahdinloo
NZNegin Zakeri
Negin Zakeri
MSMuhammad Sarfraz
Muhammad Sarfraz
SNSaeed Nezafat
Saeed Nezafat
PMParvin Milani-Zakeri
Parvin Milani-Zakeri
Purpose: Poor aqueous solubility hampers the development of several compounds as pharmacological agents. Hence, preparing novel formulations with augmented absorption is a challenge in pharmaceutical industries. In this paper, we have examined the effect of basic amino acids including arginine (ARG), lysine (LYS), and glucosamine (GlucN) on the solubility of ibuprofen (IBU) and piroxicam (PXM) as drugs with limited solubility. We have also studied the effect of the dissolution media with the pH values 1.2 to 7.4. Methods: The saturation shake-flask method was used for solubility studies in the presence of amino acids. Briefly, buffer solutions containing different concentrations of amino acids were prepared. Then, an excess amount of each drug with these buffers was shaken to reach equilibrium. After 48 hours, the upper phase was separated, and solubility was calculated by reading their UV-Vis absorbance. Results: The results illustrated that amino acids increased solubility of both drugs with different ratios, which were pH and concentration-dependent. Solubility improved as the amount of amino acids went up, and this upward pattern was more robust with ARG than LYS. The presence of GlucN in citrate buffer significantly enhanced IBU solubility. The solubility of PXM in accompany of GlucN in water did not change significantly while in citrate buffer solubility enhanced specially at pH 6. Conclusion: Overall, GlucN in citrate buffer and ARG in phosphate buffer could be introduced as the most suitable media for IBU and PXM solubility improvement, respectively.

19 June 2026 in Advanced Functional Materials
Verified
Journal Article
Open access
PDF file
SMSomayeh Mahdinloo
Somayeh Mahdinloo
PZPing‐An Zhang
Ping‐An Zhang
QZQiuyu Zhang
Qiuyu Zhang
MDMulan Deng
Mulan Deng
TLTianfeng Lan
Tianfeng Lan
JOJiang Ouyang
Jiang Ouyang
Melanoma progression is sustained by profound metabolic rewiring and immune suppression within the tumor microenvironment, where adipocyte‐derived lipid droplets (LDs) serve as key metabolic regulators. Here, we exploit this intrinsic biology by engineering resveratrol‐loaded LDs (RSV‐LDs) as natural, lipophilic nanocarriers to drive intracellular delivery and immunometabolic reprogramming. To achieve precise and localized administration, RSV‐LDs were integrated into soluble microneedles, enabling efficient transdermal delivery while minimizing systemic exposure. This strategy markedly increased the M1/M2 macrophage ratio and promoted robust CD8 + T‐cell infiltration, reshaping the immunosuppressive tumor niche. To further potentiate the activity of these infiltrating CD8 + T‐cells, we incorporated ROS‐responsive anti‐PD1 nanoparticles (aPD1‐NPs) via a thioketal linker, enabling tumor‐specific antibody release within the oxidative tumor milieu. Notably, transcriptomic and single‐cell analyses revealed coordinated activation of innate immune and metabolic pathways following treatment, with TLR7/8‐expressing monocytes emerging as a central communication hub among T, NK, and B cell populations. Together, these findings demonstrate that the microneedle‐based RSV‐LD/aPD1 platform induces localized metabolic and immune reprogramming, reshaping the tumor microenvironment to enhance antitumor immunity.